Gerard Silvestri to Clinical Trials, Phase III as Topic
This is a "connection" page, showing publications Gerard Silvestri has written about Clinical Trials, Phase III as Topic.
Connection Strength
0.063
-
Targeted therapy for the treatment of advanced non-small cell lung cancer: a review of the epidermal growth factor receptor antagonists. Chest. 2005 Dec; 128(6):3975-84.
Score: 0.063